down Go Back to Corporate Leadership It’s critical to acknowledge the contributions of immigrants and refugees to our economy. Protecting Immigrants and Refugees Amid the COVID-19 Pandemic Published may. 04, 2020 Laura Roberts Senior Director Catherine Ward Vice President, Employer Mobilization Share on Facebook Share on Twitter Share on LinkedIn Share via Email Read the Full Statement Read Moreright In the face of COVID-19 and its impacts, the WES Mariam Assefa Fund—the Beeck Center for Social Impact + Innovation, JFF, Mission Driven Finance, Upwardly Global, and the Welcoming Center for New Pennsylvanians—are proud to stand together to continue fighting for immigrants and their vital role in our economy and society. In this joint statement published on WES.org, we share our reflections on the challenges that immigrant communities face amid the COVID-19 pandemic. We also offer recommended strategies for equitable recovery as we move forward. Including:Advocating for policies that help promote equitable access to economic security in the near and long termAs government entities make decisions and take action, ensuring access to information—especially for those whose English language skills are a barrierPressing employers to commit to proactive support for workers, including paid sick leave for full-time employees and contractors, as well as guidance and training for workers who must be furloughed or laid off.Holding accountable the philanthropic community for providing the flexible capital that offers immediate relief to non-profit service providers. Read the Full Statement Read Moreright
Post Corporate America: This Is Your Time to Lead In times like these, there is a real opportunity for corporations to step out and up as leaders, using their power and influence to make a difference.
Our hope is that all investors will consider their roles in facing the challenges ahead. At ETF@JFFLabs, we seek to rise now to fulfill our responsibility. In the News Our Shared Responsibility as Impact Investors in the Face of COVID-19